Reckitt to offload homecare brands, consider nutrition options
Reckitt cuts like-for-like revenue outlook for fiscal year
Tornado hurts nutrition business, warehouse still shut
Q2 like-for-like revenue and volume miss forecasts
Nutrition sale could happen while litigation ongoing -CEO
Updates shares, adds full name of product featured in legal case
By Agata Rybska
July 24 (Reuters) -Reckitt Benckiser RKT.L will consider options for its troubled nutrition business and offload a portfolio of homecare brands by the end of 2025, it said on Wednesday, planning to refocus on healthcare and hygiene.
Reckitt's home care portfolio, which includes Air Wick air fresheners and Cillit Bang cleaner, achieved sales of around 1.9 billion pounds ($2.5 billion) last year, but the company no longer considers it a core business.
The British consumer goods firm had also been under pressure from shareholders to consider a sale of its Mead Johnson nutrition business, which sells baby formula products.
In March, an Illinois jury ordered Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil Premature 24 baby formula. The company subsequently said that many cases had been filed against baby formula makers in general, and it was unclear how many directly related to its unit's Enfamil product.
Investors reacted positively to the news that Reckitt is considering options for the business, sending its shares up more than 4% in early trading. The stock later pared some of its gains and was up 1.6% at 1415 GMT.
"This could potentially remove another overhang given this has been a rather problematic part of the business," said Richard Saldanha, a portfolio manager at Aviva.
Reckitt CEO Kris Licht did not rule out a sale of the nutrition business while litigation is ongoing.
"I would not rule that out as a possibility. I would also not say that there's any certainty in that," he told investors on a call to discuss the company's first half earnings.
Jack Martin, an investment manager at Oberon Investments, welcomed the decision to sell the homecare brands.
"The issue now turns to whether they can do that at an attractive valuation and whether the proceeds can be reinvested into brands that offer long term growth opportunities effectively," he said.
Reckitt wants to focus on what it calls its powerbrands, including Strepsils throat lozenges, Nurofen pain relief products, Dettol disinfectant, Finish dishwasher tablets, and Durex condoms.
Saldanha backed that plan.
"It certainly makes sense in our view for them to focus on allocating capital to these brands to continue to drive future growth," he said.
The strategic update overshadowed Reckitt's decision to lower its 2024 sales growth forecast.
SUPPLY DISRUPTIONS
Reckitt missed like-for-like net sales growth expectations for the second quarter. It now expects like-for-like revenue growth of 1-3% for the full year, down from its previous forecast of a 2-4% rise.
The company blamed supply disruptions at its infant formula business after a tornado damaged a third-party warehouse in the United States.
Reckitt's like-for-like revenue for the quarter was flat, against the 0.1% growth analysts had expected in a company-provided consensus. Sales volumes declined 2.2%, more than the 1.5% drop expected.
Reckitt will launch a share buyback of up to 1 billion pounds and increase its interim dividend, it said.
($1 = 0.7763 pounds)
Reporting by Agata Rybska, Editing by Matt Scuffham, Bernadette Baum and Mark Potter
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
